網膜芽細胞腫治療の世界市場：市場規模・現状・予測

• 英文タイトル：Global Retinoblastoma Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST03711 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、網膜芽細胞腫治療の世界市場について調査・分析し、網膜芽細胞腫治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（先天性（遺伝性）網膜芽腫、散発性（非遺伝性）網膜芽腫）、用途別（病院、がん研究所、薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の網膜芽細胞腫治療市場動向 ・主要企業別マーケットシェア ・網膜芽細胞腫治療の種類別市場規模2014-2019 （先天性（遺伝性）網膜芽腫、散発性（非遺伝性）網膜芽腫） ・網膜芽細胞腫治療の用途別市場規模2014-2019 （病院、がん研究所、薬局） ・網膜芽細胞腫治療の北米市場：主要企業・種類別/用途別市場規模 ・網膜芽細胞腫治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・網膜芽細胞腫治療の中国市場：主要企業・種類別/用途別市場規模 ・網膜芽細胞腫治療の日本国内市場：主要企業・種類別/用途別市場規模 ・網膜芽細胞腫治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・網膜芽細胞腫治療のインド市場：主要企業・種類別/用途別市場規模 ・網膜芽細胞腫治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Baxter、Bristol-Myers Squibb、GlaxoSmithKline、Spectrum Pharmaceuticals、BioLineRx、Cellceutix、Icon Bioscience、Neotropix、RXi Pharmaceuticals、Recombio） ・網膜芽細胞腫治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Retinoblastoma is a cancer that starts in the retina, the very back part of the eye.In 2018, the global Retinoblastoma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Retinoblastoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Retinoblastoma Treatment development in United States, Europe and China.

The key players covered in this study
Baxter
Bristol-Myers Squibb
GlaxoSmithKline
Spectrum Pharmaceuticals
BioLineRx
Cellceutix
Icon Bioscience
Neotropix
RXi Pharmaceuticals
Recombio

Market segment by Type, the product can be split into
Congenital (Hereditary) Retinoblastoma
Sporadic (Non-Hereditary) Retinoblastoma

Market segment by Application, split into
Hospitals
Cancer Institutes
Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Retinoblastoma Treatment status, future forecast, growth opportunity, key market and key players.
To present the Retinoblastoma Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Retinoblastoma Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Retinoblastoma Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Congenital (Hereditary) Retinoblastoma
1.4.3 Sporadic (Non-Hereditary) Retinoblastoma
1.5 Market by Application
1.5.1 Global Retinoblastoma Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Cancer Institutes
1.5.4 Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Retinoblastoma Treatment Market Size
2.2 Retinoblastoma Treatment Growth Trends by Regions
2.2.1 Retinoblastoma Treatment Market Size by Regions (2014-2025)
2.2.2 Retinoblastoma Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Retinoblastoma Treatment Market Size by Manufacturers
3.1.1 Global Retinoblastoma Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Retinoblastoma Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Retinoblastoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Retinoblastoma Treatment Key Players Head office and Area Served
3.3 Key Players Retinoblastoma Treatment Product/Solution/Service
3.4 Date of Enter into Retinoblastoma Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Retinoblastoma Treatment Market Size by Type (2014-2019)
4.2 Global Retinoblastoma Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Retinoblastoma Treatment Market Size (2014-2019)
5.2 Retinoblastoma Treatment Key Players in United States
5.3 United States Retinoblastoma Treatment Market Size by Type
5.4 United States Retinoblastoma Treatment Market Size by Application

6 Europe
6.1 Europe Retinoblastoma Treatment Market Size (2014-2019)
6.2 Retinoblastoma Treatment Key Players in Europe
6.3 Europe Retinoblastoma Treatment Market Size by Type
6.4 Europe Retinoblastoma Treatment Market Size by Application

7 China
7.1 China Retinoblastoma Treatment Market Size (2014-2019)
7.2 Retinoblastoma Treatment Key Players in China
7.3 China Retinoblastoma Treatment Market Size by Type
7.4 China Retinoblastoma Treatment Market Size by Application

8 Japan
8.1 Japan Retinoblastoma Treatment Market Size (2014-2019)
8.2 Retinoblastoma Treatment Key Players in Japan
8.3 Japan Retinoblastoma Treatment Market Size by Type
8.4 Japan Retinoblastoma Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Retinoblastoma Treatment Market Size (2014-2019)
9.2 Retinoblastoma Treatment Key Players in Southeast Asia
9.3 Southeast Asia Retinoblastoma Treatment Market Size by Type
9.4 Southeast Asia Retinoblastoma Treatment Market Size by Application

10 India
10.1 India Retinoblastoma Treatment Market Size (2014-2019)
10.2 Retinoblastoma Treatment Key Players in India
10.3 India Retinoblastoma Treatment Market Size by Type
10.4 India Retinoblastoma Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Retinoblastoma Treatment Market Size (2014-2019)
11.2 Retinoblastoma Treatment Key Players in Central & South America
11.3 Central & South America Retinoblastoma Treatment Market Size by Type
11.4 Central & South America Retinoblastoma Treatment Market Size by Application

12 International Players Profiles
12.1 Baxter
12.1.1 Baxter Company Details
12.1.2 Company Description and Business Overview
12.1.3 Retinoblastoma Treatment Introduction
12.1.4 Baxter Revenue in Retinoblastoma Treatment Business (2014-2019)
12.1.5 Baxter Recent Development
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Company Details
12.2.2 Company Description and Business Overview
12.2.3 Retinoblastoma Treatment Introduction
12.2.4 Bristol-Myers Squibb Revenue in Retinoblastoma Treatment Business (2014-2019)
12.2.5 Bristol-Myers Squibb Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Retinoblastoma Treatment Introduction
12.3.4 GlaxoSmithKline Revenue in Retinoblastoma Treatment Business (2014-2019)
12.3.5 GlaxoSmithKline Recent Development
12.4 Spectrum Pharmaceuticals
12.4.1 Spectrum Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Retinoblastoma Treatment Introduction
12.4.4 Spectrum Pharmaceuticals Revenue in Retinoblastoma Treatment Business (2014-2019)
12.4.5 Spectrum Pharmaceuticals Recent Development
12.5 BioLineRx
12.5.1 BioLineRx Company Details
12.5.2 Company Description and Business Overview
12.5.3 Retinoblastoma Treatment Introduction
12.5.4 BioLineRx Revenue in Retinoblastoma Treatment Business (2014-2019)
12.5.5 BioLineRx Recent Development
12.6 Cellceutix
12.6.1 Cellceutix Company Details
12.6.2 Company Description and Business Overview
12.6.3 Retinoblastoma Treatment Introduction
12.6.4 Cellceutix Revenue in Retinoblastoma Treatment Business (2014-2019)
12.6.5 Cellceutix Recent Development
12.7 Icon Bioscience
12.7.1 Icon Bioscience Company Details
12.7.2 Company Description and Business Overview
12.7.3 Retinoblastoma Treatment Introduction
12.7.4 Icon Bioscience Revenue in Retinoblastoma Treatment Business (2014-2019)
12.7.5 Icon Bioscience Recent Development
12.8 Neotropix
12.8.1 Neotropix Company Details
12.8.2 Company Description and Business Overview
12.8.3 Retinoblastoma Treatment Introduction
12.8.4 Neotropix Revenue in Retinoblastoma Treatment Business (2014-2019)
12.8.5 Neotropix Recent Development
12.9 RXi Pharmaceuticals
12.9.1 RXi Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Retinoblastoma Treatment Introduction
12.9.4 RXi Pharmaceuticals Revenue in Retinoblastoma Treatment Business (2014-2019)
12.9.5 RXi Pharmaceuticals Recent Development
12.10 Recombio
12.10.1 Recombio Company Details
12.10.2 Company Description and Business Overview
12.10.3 Retinoblastoma Treatment Introduction
12.10.4 Recombio Revenue in Retinoblastoma Treatment Business (2014-2019)
12.10.5 Recombio Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Retinoblastoma Treatment Key Market Segments
Table Key Players Retinoblastoma Treatment Covered
Table Global Retinoblastoma Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Retinoblastoma Treatment Market Size Market Share by Type 2014-2025
Figure Congenital (Hereditary) Retinoblastoma Figures
Table Key Players of Congenital (Hereditary) Retinoblastoma
Figure Sporadic (Non-Hereditary) Retinoblastoma Figures
Table Key Players of Sporadic (Non-Hereditary) Retinoblastoma
Table Global Retinoblastoma Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Cancer Institutes Case Studies
Figure Pharmacies Case Studies
Figure Retinoblastoma Treatment Report Years Considered
Table Global Retinoblastoma Treatment Market Size 2014-2025 (Million US$)
Figure Global Retinoblastoma Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Retinoblastoma Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Retinoblastoma Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Retinoblastoma Treatment Market Share by Regions 2014-2019
Figure Global Retinoblastoma Treatment Market Share by Regions 2014-2019
Figure Global Retinoblastoma Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Retinoblastoma Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Retinoblastoma Treatment Market Share by Manufacturers (2014-2019)
Figure Global Retinoblastoma Treatment Market Share by Manufacturers in 2018
Table Global Retinoblastoma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Retinoblastoma Treatment Product/Solution/Service
Table Date of Enter into Retinoblastoma Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Retinoblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Retinoblastoma Treatment Market Size Share by Type (2014-2019)
Figure Global Retinoblastoma Treatment Market Size Market Share by Type (2014-2019)
Table Global Retinoblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Retinoblastoma Treatment Market Size Share by Application (2014-2019)
Figure Global Retinoblastoma Treatment Market Size Market Share by Application (2014-2019)
Figure Global Retinoblastoma Treatment Revenue Market Share by Application in 2018
Figure United States Retinoblastoma Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Retinoblastoma Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Retinoblastoma Treatment Market Share (2018-2019)
Table United States Retinoblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Retinoblastoma Treatment Market Share by Type (2014-2019)
Table United States Retinoblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Retinoblastoma Treatment Market Share by Application (2014-2019)
Figure Europe Retinoblastoma Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Retinoblastoma Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Retinoblastoma Treatment Market Share (2018-2019)
Table Europe Retinoblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Retinoblastoma Treatment Market Share by Type (2014-2019)
Table Europe Retinoblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Retinoblastoma Treatment Market Share by Application (2014-2019)
Figure China Retinoblastoma Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Retinoblastoma Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Retinoblastoma Treatment Market Share (2018-2019)
Table China Retinoblastoma Treatment Market Size by Type (2014-20189) (Million US$)
Table China Retinoblastoma Treatment Market Share by Type (2014-2019)
Table China Retinoblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table China Retinoblastoma Treatment Market Share by Application (2014-2019)
Figure Japan Retinoblastoma Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Retinoblastoma Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Retinoblastoma Treatment Market Share (2018-2019)
Table Japan Retinoblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Retinoblastoma Treatment Market Share by Type (2014-2019)
Table Japan Retinoblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Retinoblastoma Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Retinoblastoma Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Retinoblastoma Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Retinoblastoma Treatment Market Share (2018-2019)
Table Southeast Asia Retinoblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Retinoblastoma Treatment Market Share by Type (2014-2019)
Table Southeast Asia Retinoblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Retinoblastoma Treatment Market Share by Application (2014-2019)
Figure India Retinoblastoma Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Retinoblastoma Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Retinoblastoma Treatment Market Share (2018-2019)
Table India Retinoblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table India Retinoblastoma Treatment Market Share by Type (2014-2019)
Table India Retinoblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table India Retinoblastoma Treatment Market Share by Application (2014-2019)
Figure Central & South America Retinoblastoma Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Retinoblastoma Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Retinoblastoma Treatment Market Share (2018-2019)
Table Central & South America Retinoblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Retinoblastoma Treatment Market Share by Type (2014-2019)
Table Central & South America Retinoblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Retinoblastoma Treatment Market Share by Application (2014-2019)
Table Baxter Company Details
Table Baxter Revenue in Retinoblastoma Treatment Business (2014-2019) (Million US$)
Figure Baxter Revenue Growth Rate in Retinoblastoma Treatment Business (2014-2019)
Table Baxter Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Retinoblastoma Treatment Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Retinoblastoma Treatment Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Retinoblastoma Treatment Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Retinoblastoma Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Spectrum Pharmaceuticals Company Details
Table Spectrum Pharmaceuticals Revenue in Retinoblastoma Treatment Business (2014-2019)(Million US$)
Figure Spectrum Pharmaceuticals Revenue Growth Rate in Retinoblastoma Treatment Business (2014-2019)
Table Spectrum Pharmaceuticals Recent Development
Table BioLineRx Company Details
Table BioLineRx Revenue in Retinoblastoma Treatment Business (2014-2019)(Million US$)
Figure BioLineRx Revenue Growth Rate in Retinoblastoma Treatment Business (2014-2019)
Table BioLineRx Recent Development
Table Cellceutix Company Details
Table Cellceutix Revenue in Retinoblastoma Treatment Business (2014-2019)(Million US$)
Figure Cellceutix Revenue Growth Rate in Retinoblastoma Treatment Business (2014-2019)
Table Cellceutix Recent Development
Table Icon Bioscience Company Details
Table Icon Bioscience Revenue in Retinoblastoma Treatment Business (2014-2019)(Million US$)
Figure Icon Bioscience Revenue Growth Rate in Retinoblastoma Treatment Business (2014-2019)
Table Icon Bioscience Recent Development
Table Neotropix Company Details
Table Neotropix Revenue in Retinoblastoma Treatment Business (2014-2019)(Million US$)
Figure Neotropix Revenue Growth Rate in Retinoblastoma Treatment Business (2014-2019)
Table Neotropix Recent Development
Table RXi Pharmaceuticals Company Details
Table RXi Pharmaceuticals Revenue in Retinoblastoma Treatment Business (2014-2019)(Million US$)
Figure RXi Pharmaceuticals Revenue Growth Rate in Retinoblastoma Treatment Business (2014-2019)
Table RXi Pharmaceuticals Recent Development
Table Recombio Company Details
Table Recombio Revenue in Retinoblastoma Treatment Business (2014-2019)(Million US$)
Figure Recombio Revenue Growth Rate in Retinoblastoma Treatment Business (2014-2019)
Table Recombio Recent Development
Table Global Retinoblastoma Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Retinoblastoma Treatment Market Size Share by Regions (2019-2025)
Figure Global Retinoblastoma Treatment Market Size Share by Regions in 2025
Figure United States Retinoblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Retinoblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Retinoblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Retinoblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Retinoblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Retinoblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Retinoblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Retinoblastoma Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Retinoblastoma Treatment Market Size by Product (2019-2025)
Figure Global Retinoblastoma Treatment Market Size by Product in 2025
Table Global Retinoblastoma Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Retinoblastoma Treatment Market Size by Application (2019-2025)
Figure Global Retinoblastoma Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---